7-Arylpiperazinylalkyl and 7-tetrahydroisoquinolinylalkyl derivatives of 8-alkoxy-purine-2,6-dione and some of their purine-2,6,8-trione analogs as 5-HT1A, 5-HT2A, and 5-HT7 serotonin receptor ligands-Reference-Cited by-同舟云学术

7-Arylpiperazinylalkyl and 7-tetrahydroisoquinolinylalkyl derivatives of 8-alkoxy-purine-2,6-dione and some of their purine-2,6,8-trione analogs as 5-HT1A, 5-HT2A, and 5-HT7 serotonin receptor ligands

Published:2007-08 Issue:15 Volume:15 Page:5239-5250
ISSN:0968-0896
Container-title:Bioorganic & Medicinal Chemistry
language:en
Short-container-title:Bioorganic & Medicinal Chemistry

Author:

Chłoń-Rzepa Grażyna,Żmudzki Paweł,Zajdel Paweł,Bojarski Andrzej J.,Duszyńska Beata,Nikiforuk Agnieszka,Tatarczyńska Ewa,Pawłowski Maciej

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference26 articles.

1. Functional, molecular and pharmacological advances in 5-HT receptor research

2. Serotonin7 Receptors (5-HT7Rs)and their Ligands

3. 3-(ω-Aminoalkyl)-5,5-dialkyl(or spirocycloalkyl-1′,5-)hydantoins as New 5-HT1A and 5-HT2A Receptor Ligands

4. Arylpiperazines with N-acylated amino acids as 5-HT1A receptor ligands

5. A new putative 5-HT1A receptor antagonist of the 1-arylpiperazine class of ligands

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Designing multi-target drugs for the treatment of major depressive disorder;Expert Opinion on Drug Discovery;2023-05-19

2. Recent advances in dopamine D ₂ receptor ligands in the treatment of neuropsychiatric disorders;Medicinal Research Reviews;2022-09-16

3. A New Paradigm Shift in Antidepressant Therapy: From Dual-action to Multitarget-directed Ligands;Current Medicinal Chemistry;2022-09

4. Antidepressant Drug Discovery and Development: Mechanism and Drug Design Based on Small Molecules;Advanced Therapeutics;2022-03-30

5. Design strategies, chemistry and therapeutic insights of multi-target directed ligands as antidepressant agents;Current Neuropharmacology;2021-11-02